Tijana Trivić

ORCID: 0000-0003-2566-253X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Mosquito-borne diseases and control
  • Drug-Induced Adverse Reactions
  • interferon and immune responses
  • Inflammasome and immune disorders
  • Urticaria and Related Conditions
  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research
  • Psoriasis: Treatment and Pathogenesis

Charles University
2022-2024

University of Lausanne
2024

Institute of Virology, Vaccines and Sera “Torlak”
2024

Abstract Interleukin-17A (IL-17A) is a key mediator of protective immunity to yeast and bacterial infections but also drives the pathogenesis several autoimmune diseases, such as psoriasis or psoriatic arthritis. Here we show that tetra-transmembrane protein CMTM4 subunit IL-17 receptor (IL-17R). constitutively associated with IL-17R C mediate its stability, glycosylation plasma membrane localization. Both mouse human cell lines deficient in were largely unresponsive IL-17A, due their...

10.1038/s41590-022-01325-9 article EN cc-by Nature Immunology 2022-10-21

Abstract The cytokine TNF can trigger highly proinflammatory RIPK1-dependent cell death. Here, we show that the two adapter proteins, TANK and AZI2, suppress TNF-induced death by regulating activation of TBK1 kinase. Mice lacking either or AZI2 do not an overt phenotype. Conversely, animals deficient in both adapters are born a sub-Mendelian ratio suffer from severe multi-organ inflammation, excessive antibody production, male sterility, early mortality, which be rescued TNFR1 deficiency...

10.1038/s41467-024-54399-4 article EN cc-by Nature Communications 2024-11-19
Coming Soon ...